Hepatitis C medicines for NHS Wales
6 November 2026 at 12:00; time zone not stated
Time not stated
Contract value
£6,549,650.36
Estimated total contract value, excluding VAT
Contract period
1 May 2027–30 April 2029, with an extension option of up to two years
Published
October 6, 2026
Official Sell2Wales public notice
Overview
NHS Wales is seeking antiviral medicines for hepatitis C treatment.
Information based on the public notice
Ask about this tender
What the buyer needs
The open procedure seeks antiviral medicines for treating hepatitis C for NHS Wales. The estimated contract value is £6,549,650.36 excluding VAT. The initial term is 1 May 2027 to 30 April 2029, with an extension option of up to two years. Price carries 85% weighting, environmental/social value 15%, and product quality is pass/fail.
Tender details
- Buyer
- NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- Country
United Kingdom
- Procedure
- UK4
- Classification
- Pharmaceuticals
- Notice reference
- OCT665369 · PHA-FTS-63590
- estimated value
- £6,549,650.36 excluding VAT
- term
- 1 May 2027–30 April 2029
- extensions
- Up to two years
- deadline
- 6 November 2026 at 12:00 (time zone not stated)
What to check in the tender documents
- The public notice refers participation conditions and product specifications to separate tender documents, which were not accessed.
Original notice
Read the original description
Hepatitis C Medicines
Summary OCID: ocds-h6vhtk-066b74 Published by: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) Authority ID: AA0221 Publication date: 07 October 2026 Deadline date: 06 November 2026 Notice type: UK4 Has documents: No Has SPD: No Has Carbon Reduction Plan: N/A Abstract This tender is for the provision of antiviral medicines for the treatment of Hepatitis C (HCV) to NHS Wales.
Procurement reference PHA-FTS-63590
Procurement description This tender is for the provision of antiviral medicines for the treatment of Hepatitis C (HCV) to NHS Wales.
Main category Goods
Delivery regions UKL - Wales
Total value (estimated, excluding VAT) 6549650.36 GBP to 6549650.36GBP
Contract dates (estimated) 01 May 2027, 00:00AM to 30 April 2029, 23:59PM Extension end date (if all the extensions are used): 30 April 2031
Procedure type Open procedure
CPV classifications 33600000 - Pharmaceutical products
Delivery regions UKL - Wales
Lot value (estimated) 6549650.36 GBP Excluding VAT 7859580.43 GBP Including VAT
Contract start date (estimated) 01 May 2027, 00:00AM
Contract end date (estimated) 30 April 2029, 23:59PM
Extension end date (estimated) 30 April 2031, 23:59PM
Can the contract be extended? Yes
Description of extensions Extension option of up to 2 years available
Participation Conditions Economic Conditions of participation As per the tender documents Conditions Economic Conditions of participation As per the tender documents
Award criteria Type: quality Name Product Quality/Acceptability Description Pass/Fail Weighting: 1 Weighting type: order Type: cost Name Financial (Overall Cost of Contract) Description Weighting: 85 Weighting: 2 Weighting type: order Type: quality Name Environmental/Social Value/Community Benefits Description Weighting: 15 Weighting: 3 Weighting type: order
Tender submission deadline 06 November 2026, 12:00PM
Enquiry deadline 02 November 2026, 12:00PM
Date of award of contract 26 February 2027, 23:59PM
Submission address and any special instructions https://etenderwales.ukp.app.jaggaer.com/home.html
May tenders be submitted electronically? Yes
Languages that may be used for submission English
Official source: Official Sell2Wales public notice ↗
https://zephior.com/tenders/3942eaa0-e5ee-4d7d-805d-8178c4413ac4/pharmaceuticals-3942eaa0
https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=OCT665369
Source retrieved: 2026-10-13T00:15:49.130214Z
https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=OCT665369
Source retrieved: 2026-10-13T00:15:49.130214Z